Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shafia Rahman

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal of Gastrointestinal Cancer|July 2, 2025
Role of Neoadjuvant Therapy for Patients with Adenosquamous Carcinoma of the Pancreas: Outcomes from the National Cancer DatabaseAmanda K Walsh, Diamantis I Tsilimigras, Alex B Blair, et al.
Thrombosis and Haemostasis|November 13, 2020
Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on MortalityHenny H Billett, Morayma Reyes-Gil, James Szymanski, et al.
Annals of Hepato-Biliary-Pancreatic Surgery|January 27, 2026
Simultaneous resection of pancreatic cancer and liver metastases following total neoadjuvant therapy: A case series and analysis of the National Cancer DatabaseMcKenzie L Schaefer, Patrick L Quinn, Alexander H Shannon, et al.
Gastroenterology Research|January 13, 2025
Risk Factors Predicting Outcomes in Advanced Upper Gastrointestinal Cancers Treated With Immune Checkpoint InhibitorsAshish Manne, Fode Tounkara, Eric Min, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 14, 2025
Hospital admission during neoadjuvant therapy for pancreatic ductal adenocarcinoma: prevalence, predictors, and prognosisPatrick W Underwood, Thomas Leuschner, Amanda K Walsh, et al.
NPJ Precision Oncology|February 26, 2026
Clinical and molecular characteristics of Class II and III BRAF mutations in colorectal cancerIbrahim Halil Sahin, Joanne Xiu, Yasmine Baca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2025
Riluzole in Combination with mFOLFOX6 and Bevacizumab in Treating Patients with Metastatic Colorectal Cancer: A Phase I Clinical TrialChunjie Li, Anne M Noonan, John Hays, et al.
International Journal of Molecular Sciences|August 29, 2024
Mature MUC5AC Expression in Resected Pancreatic Ductal Adenocarcinoma Predicts Treatment Response and OutcomesAshish Manne, Ashwini Esnakula, Ankur Sheel, et al.
JCO Precision Oncology|July 25, 2025
CNS Involvement by North American-Adult T-cell Leukemia/Lymphoma Is Associated With Discrete Dissemination Patterns and Molecular Profiles, Involving XPO1 E571 and KLF2/PI3KCD in Selected CasesNishi Shah, Melissa Suchanek, Astha Thakkar, et al.
Cancer Cell|June 16, 2021
Seroconversion rates following COVID-19 vaccination among patients with cancerAstha Thakkar, Jesus D Gonzalez-Lugo, Niyati Goradia, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Gastrointestinal Cancer|July 2, 2025
Role of Neoadjuvant Therapy for Patients with Adenosquamous Carcinoma of the Pancreas: Outcomes from the National Cancer DatabaseAmanda K Walsh, Diamantis I Tsilimigras, Alex B Blair, et al.
Thrombosis and Haemostasis|November 13, 2020
Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on MortalityHenny H Billett, Morayma Reyes-Gil, James Szymanski, et al.
Annals of Hepato-Biliary-Pancreatic Surgery|January 27, 2026
Simultaneous resection of pancreatic cancer and liver metastases following total neoadjuvant therapy: A case series and analysis of the National Cancer DatabaseMcKenzie L Schaefer, Patrick L Quinn, Alexander H Shannon, et al.
Gastroenterology Research|January 13, 2025
Risk Factors Predicting Outcomes in Advanced Upper Gastrointestinal Cancers Treated With Immune Checkpoint InhibitorsAshish Manne, Fode Tounkara, Eric Min, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 14, 2025
Hospital admission during neoadjuvant therapy for pancreatic ductal adenocarcinoma: prevalence, predictors, and prognosisPatrick W Underwood, Thomas Leuschner, Amanda K Walsh, et al.
NPJ Precision Oncology|February 26, 2026
Clinical and molecular characteristics of Class II and III BRAF mutations in colorectal cancerIbrahim Halil Sahin, Joanne Xiu, Yasmine Baca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2025
Riluzole in Combination with mFOLFOX6 and Bevacizumab in Treating Patients with Metastatic Colorectal Cancer: A Phase I Clinical TrialChunjie Li, Anne M Noonan, John Hays, et al.
International Journal of Molecular Sciences|August 29, 2024
Mature MUC5AC Expression in Resected Pancreatic Ductal Adenocarcinoma Predicts Treatment Response and OutcomesAshish Manne, Ashwini Esnakula, Ankur Sheel, et al.
JCO Precision Oncology|July 25, 2025
CNS Involvement by North American-Adult T-cell Leukemia/Lymphoma Is Associated With Discrete Dissemination Patterns and Molecular Profiles, Involving XPO1 E571 and KLF2/PI3KCD in Selected CasesNishi Shah, Melissa Suchanek, Astha Thakkar, et al.
Cancer Cell|June 16, 2021
Seroconversion rates following COVID-19 vaccination among patients with cancerAstha Thakkar, Jesus D Gonzalez-Lugo, Niyati Goradia, et al.
Pageof 3